Complete Genomics ETF Forecast

Buy or Hold candidate since May 27, 2026 Gain 22.05%

The Complete Genomics, Inc ETF price gained 2.08% on the last trading day (Thursday, 9th Jul 2026), rising from $57.34 to $58.54. During the last trading day the ETF fluctuated 1.06% from a day low at $58.17 to a day high of $58.79. The price has risen in 7 of the last 10 days and is up by 8.85% over the past 2 weeks. Volume fell on the last day by -6 thousand shares and in total, 17 thousand shares were bought and sold for approximately $974.77 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The ETF lies in the upper part of a wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $59.43 will firstly indicate a stronger rate of rising. Given the current short-term trend, the ETF is expected to rise 25.89% during the next 3 months and, with a 90% probability hold a price between $63.84 and $74.81 at the end of this 3-month period.

GNOM Signals & Forecast

The Complete Genomics, Inc ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the ETF. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $58.01 and $51.42. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, July 06, 2026, and so far it has fallen -0.492%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Complete Genomics, Inc ETF

Complete Genomics, Inc finds support from accumulated volume at $57.12 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This ETF may move much during the day (volatility) and with periodic low trading volume this ETF is considered to be "high risk". During the last day, the ETF moved $0.615 between high and low, or 1.06%. For the last week the ETF has had daily average volatility of 2.28%.

The Complete Genomics, Inc ETF is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some ETFS may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the ETF manages to break the trend before that occurs.

Our recommended stop-loss: $56.77 (-3.03%) (This ETF has high daily movements and this gives high risk. The RSI14 is 82 and this increases the risk substantially. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (GNOM) For The Upcoming Trading Day Of Friday 10th

For the upcoming trading day on Friday, 10th we expect Complete Genomics, Inc to open at $58.50, and during the day (based on 14 day Average True Range), to move between $57.81 and $59.26, which gives a possible trading interval of +/-$1.45 (+/-2.51%) up or down from last closing price. If Complete Genomics, Inc takes out the full calculated possible swing range there will be an estimated 2.51% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $58.83 (0.49%) than the support at $57.12 (2.42%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Complete Genomics, Inc ETF A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Complete Genomics, Inc ETF to perform well in the short-term.

Current score: 2.074 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 10, 2026 - $58.50 ( 0.0683%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk